Assignee
ABVITRO LLC
US·14 granted patents·6 pending applications·42 citations·filing 2014–2022
Top patents by PatentIndex Score
20 records- 0194US10392614B2Methods of single-cell barcoding and sequencingABVITRO LLC·Filed 2017·Granted Aug 27, 2019·8 cites·19 claims
- 0294US10393743B2Methods of selecting T cell receptors using affinity oligonucleotide conjugatesABVITRO LLC·Filed 2017·Granted Aug 27, 2019·10 cites·31 claims
- 0393US10876107B2Single cell bar-coding for antibody discoveryABVITRO LLC·Filed 2018·Granted Dec 29, 2020·8 cites·13 claims
- 0491US10119134B2Single cell bar-coding for antibody discoveryABVITRO LLC·Filed 2014·Granted Nov 6, 2018·8 cites·23 claims
- 0589US10590483B2High-throughput nucleotide library sequencingABVITRO LLC·Filed 2015·Granted Mar 17, 2020·7 cites·39 claims
- 0682US11061030B2Affinity-oligonucleotide conjugates and uses thereofABVITRO LLC·Filed 2019·Granted Jul 13, 2021·1 cites·12 claims
- 0778US12129462B2Single cell bar-coding for antibody discoveryABVITRO LLC·Filed 2021·Granted Oct 29, 2024·0 cites·20 claims
- 0876US11118176B2Single cell bar-coding for antibody discoveryABVITRO LLC·Filed 2019·Granted Sep 14, 2021·0 cites·18 claims
- 0974US2022065856A1Affinity-oligonucleotide conjugates and uses thereofABVITRO LLC·Filed 2021·Application pending·0 cites
- 1073US2024076732A1High-throughput nucleotide library sequencingABVITRO LLC·Filed 2022·Application pending·0 cites
- 1165US2021293812A1High throughput process for t cell receptor target identification of natively-paired t cell receptor sequencesABVITRO LLC·Filed 2021·Application pending·0 cites
- 1264US11572403B2Broadly neutralizing anti-HIV-1 antibodies that bind to an N-glycan epitope on the envelopeABVITRO LLC·Filed 2020·Granted Feb 7, 2023·0 cites·23 claims
- 1363US11156611B2Single cell characterization using affinity-oligonucleotide conjugates and vessel barcoded polynucleotidesABVITRO LLC·Filed 2016·Granted Oct 26, 2021·0 cites·23 claims
- 1461US2020239955A1High-throughput nucleotide library sequencingABVITRO LLC·Filed 2020·Application pending·0 cites
- 1559US10928392B2High throughput process for T cell receptor target identification of natively-paired T cell receptor sequencesABVITRO LLC·Filed 2016·Granted Feb 23, 2021·0 cites·36 claims
- 1657US2021079454A1Methods of Sequencing, Determining, Pairing, and Validating Therapeutic Agents and Disease Specific AntigensABVITRO LLC·Filed 2020·Application pending·0 cites
- 1754US11142565B2Broadly neutralizing anti-HIV-1 antibodies that bind to an N-glycan epitope on the envelopeABVITRO LLC·Filed 2016·Granted Oct 12, 2021·0 cites·24 claims
- 1853US10982258B2Methods of sequencing, determining, pairing, and validating therapeutic agents and disease specific antigensABVITRO LLC·Filed 2016·Granted Apr 20, 2021·0 cites·37 claims
- 1943US12049667B2High-throughput polynucleotide library sequencing and transcriptome analysisABVITRO LLC·Filed 2018·Granted Jul 30, 2024·0 cites·33 claims
- 2042US2018274021A1Single amplicon activated exclusion pcrABVITRO LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ABVITRO LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →